How would updated results of ECOG 3311 (56 month) influence your adjuvant RT recommendations for HPV+ OPSCC?  

Would you consider de-escalation to 50 Gy for patients who meet the intermediate risk criteria? Are you more likely to offer adjuvant RT to patients with 1 positive node as the sole indication?